Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Rade M, Grieb N, Weiss R, Sia J, Fischer L, Born P, Boldt A, Fricke S, Franz P, Scolnick J, Venkatraman L, Xu S, Kloetzer C, Heyn S, Kubasch AS, Baber R, Wang SY, Bach E, Hoffmann S, Ussmann J, Schetschorke B, Hell S, Schwind S, Metzeler KH, Herling M, Jentzsch M, Franke GN, Sack U, Köhl U, Platzbecker U, Reiche K, Vucinic V, Merz M. Rade M, et al. Among authors: platzbecker u. Nat Cancer. 2024 Apr 19. doi: 10.1038/s43018-024-00763-8. Online ahead of print. Nat Cancer. 2024. PMID: 38641734
The wolf of hypomethylating agent failure: what comes next?
Kubasch AS, Platzbecker U. Kubasch AS, et al. Among authors: platzbecker u. Haematologica. 2019 Aug;104(8):1505-1508. doi: 10.3324/haematol.2019.222794. Haematologica. 2019. PMID: 31366462 Free PMC article. No abstract available.
The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy.
Tunger A, Sommer U, Wehner R, Kubasch AS, Grimm MO, Bachmann MP, Platzbecker U, Bornhäuser M, Baretton G, Schmitz M. Tunger A, et al. Among authors: platzbecker u. J Clin Med. 2019 Sep 25;8(10):1534. doi: 10.3390/jcm8101534. J Clin Med. 2019. PMID: 31557787 Free PMC article. Review.
Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy.
Schwind S, Jentzsch M, Bach E, Stasik S, Thiede C, Platzbecker U. Schwind S, et al. Among authors: platzbecker u. Curr Treat Options Oncol. 2020 Jan 30;21(1):8. doi: 10.1007/s11864-019-0695-5. Curr Treat Options Oncol. 2020. PMID: 32002673 Review.
576 results